top of page

BackTable / Tumor Board / Podcast / Episode #4

Curative Intent Therapies for HCC: Today & Tomorrow

with Dr. Kirema Garcia-Reyes, Dr. Kevin Burns, Dr. Sabeen Dhand and Dr. Zach Berman

For hepatocellular carcinoma (HCC) patients who are not candidates for liver transplant or resection, lesion ablation can be a curative treatment. With multiple ablation options available and still under investigation, it can be challenging to navigate the differences between them. In this episode, Dr. Tyler Sandow hosts a discussion with interventional radiologists Dr. Kirema Garcia-Reyes, Dr. Sabeen Dhand, and Dr. Kevin Burns on the various ablation options for HCC and when to use each one.

This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific.

AstraZeneca Pharmaceuticals
Boston Scientific
Curative Intent Therapies for HCC: Today & Tomorrow with Dr. Kirema Garcia-Reyes, Dr. Kevin Burns, Dr. Sabeen Dhand and Dr. Zach Berman on the BackTable Tumor Board Podcast
Ep 4 Curative Intent Therapies for HCC: Today & Tomorrow with Dr. Kirema Garcia-Reyes, Dr. Kevin Burns, Dr. Sabeen Dhand and Dr. Zach Berman
00:00 / 01:04

BackTable, LLC (Producer). (2025, January 17). Ep. 4 – Curative Intent Therapies for HCC: Today & Tomorrow [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Zach Berman on the BackTable VI Podcast

Dr. Zachary Berman is an interventional radiologist at the University of California San Diego in San Diego, California.

Dr. Kevin Burns on the BackTable Tumor Board Podcast

Dr. Kevin Burns is the chief of interventional radiology at Mission Hospital in Mission Viejo, California.

Dr. Sabeen Dhand on the BackTable VI Podcast

Dr. Sabeen Dhand is a practicing interventional radiologist with PIH Health in Los Angeles.

Dr. Kirema Garcia-Reyes on the BackTable Tumor Board Podcast

Dr. Kirema Garcia-Reyes is an interventional radiologist and assistant professor with Mount Sinai in New York City.

Dr. Tyler Sandow on the BackTable VI Podcast

Dr. Tyler Sandow is a diagnostic and interventional radiologist at Ochsner Health in Jefferson, Louisiana.

Synopsis

The doctors first discuss Barcelona-Clinic Liver Cancer (BCLC) Stage A patients, where lesion size and location are key factors in deciding between ablation and transarterial therapies. They then compare cryoablation and microwave ablation, highlighting that cryoablation offers better visualization and control of the ablation zone, while microwave ablation is more effective for treating larger lesions.

Dr. Burns introduces histotripsy, a noninvasive treatment that uses ultrasound energy to mechanically ablate tumors. He shares his experiences as an early adopter of this technology and discusses how intraoperative cone beam CT can help treat lesions located near critical structures or those poorly visualized on ultrasound. Finally, Dr. Garcia-Reyes and Dr. Berman provide insights into patient selection, pre-procedural imaging, and technical tips for Y90.

Timestamps

00:00 - Introduction
02:04 - Ablation vs Y90 in BCLC A Patients
05:58 - Same-Day Y90
15:55 - Y90 for Large Tumors
17:51 - Ideal Cases for Cryoablation
19:38 - Explanation of Histotripsy
32:09 - Procedural Specifics for Histotripsy
38:21 - Technical Tips for Y90

Resources

Including the Hollow Viscera (Stomach or Bowel) within the Ice Ball during Cryoablation: A Review of Adverse Events (Abramyan et al, 2024):
https://www.jvir.org/article/S1051-0443(24)00681-X/abstract

CME Accreditation Information:
https://f7cae4ec-b69e-490d-9e0f-19b16a6f146d.usrfiles.com/ugd/f7cae4_a7c37ea3cd1b4d3fa53d5edf8dfe255b.pdf

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

NSCLC Treatment: Bispecific Antibodies & EGFR Mutations with Dr. Wade Iams on the BackTable Tumor Board Podcast
Pulse Electrical Field Ablation: Lung Cancer Applications & Benefits with Dr. William Moore and Dr. Daniel Sterman on the BackTable Tumor Board Podcast
ESMO Update: Advances in Upper GI Malignancies with Dr. Jun Gong and Dr. Jonathan Mizrahi on the BackTable Tumor Board Podcast
ESMO Update: Trial Results & New Therapies in Colorectal Cancer with Dr. Jun Gong and Dr. Jonathan Mizrahi on the BackTable Tumor Board Podcast
Lung Ablation: Techniques, Challenges & Best Practices with Dr. Alan Lee, Dr. Scott Oh and Dr. Rob Suh on the BackTable Tumor Board Podcast
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du on the BackTable Tumor Board Podcast

Articles

Topics

Clinical Trials Podcasts
Histotripsy Podcasts
Immunotherapy Podcasts
Liver Cancer Podcasts
Liver Microwave Ablation Podcasts
Oncology Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

bottom of page